NCP-5

· Renew Research, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NCP-5, covering 2022-04-19 to 2022-04-19. Get the full timeline:

Most recent: Clinical Trial Update: Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type [Phase 3]

See pricing